Curemark Revenue and Competitors

Rye, NY USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Curemark's estimated annual revenue is currently $4.3M per year.(i)
  • Curemark's estimated revenue per employee is $155,000

Employee Data

  • Curemark has 28 Employees.(i)
  • Curemark grew their employee count by 4% last year.

Curemark's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
Chief Staff at CuremarkReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
VP Manufacturing Sciences and TechnologyReveal Email/Phone
5
SVP, Corporate Strategy & FinanceReveal Email/Phone
6
Director Clincal OperationsReveal Email/Phone
7
Senior Director OperationsReveal Email/Phone
8
Medical DirectorReveal Email/Phone
9
AdvisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M40%N/AN/A
#2
$3.7M2441%$44MN/A
#3
$6.2M40-7%N/AN/A
#4
$42M271-1%N/AN/A
#5
$12.7M820%$10MN/A
#6
$2.5M160%N/AN/A
#7
$7.5M450%$51.6MN/A
#8
$0.2M1-50%N/AN/A
#9
$4.3M26-16%$3.3MN/A
#10
$3.7M244%N/AN/A
Add Company

What Is Curemark?

Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark's pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson's disease.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Curemark News

2022-04-17 - How being more flexible can benefit your life, career

Joan Fallon is the founder and CEO of Curemark, and is considered a visionary scientist who has dedicated her life's work to championing the...

2022-04-13 - Autism Spectrum Disorder Diagnostics Market Size, Scope ...

Autism Spectrum Disorder Diagnostics Market Size, Scope And Forecast | Leading Players – Pfizer, Merck, Roche, SynapDx, Curemark.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M3015%N/A
#2
$6M30-14%N/A
#3
$6.9M327%N/A
#4
$5.6M323%N/A
#5
$6.4M3922%N/A